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Susceptibility to apoptosis is differentially regulated by c-myc and
mutated Ha-ras oncogenes and is associated with endonuclease
availability
M.J. Arends, A.H. McGregor, N.J. Toft, E.J.H. Brown & A.H. Wyllie
Cancer Research Campaign Laboratories, Department of Pathology, University Medical School, Teviot Place, Edinburgh
EH8 9AG. UK.
Summary Oncogenes and oncosuppressors can derugulate cell replication in tumours, and recently have been
shown to influence the probability of apoptosis. The effects of human c-myc and mutated (T24) Ha-ras
oncogenes on susceptibility to apoptosis were investigated by introducting them into immortalised rat
fibroblasts. The resulting family of transfectants showed closely similar measures of proliferation, but widely
divergent rates of apoptosis, differing by up to fifteen-fold, that correlated inversely with population expansion
rates in vitro. T24-ras transfectants with moderate or high p2lras expression showed reduced apoptosis, and
this was reversed by pharmacological inhibition of membrane localisation of p2l's by mevinolin. In contrast,
c-myc stimulated apoptosis, and this was further enhanced by serum deprivation. Inducibility of effector
proteins represents one possible mechanism of genetic control of the susceptibility to apoptosis, and its
investigation showed that c-myc was associated with expression by viable cells of latent calcium/magnesium
sensitive endonuclease activity characteristic of apoptosis. In contrast, endonuclease activity was not detected
in viable cells of a T24-ras transfectant expressing high levels of p2lras. Thus, there appeared to be differential
regulation of susceptibility to apoptosis, positively by c-myc and negatively by activated ras, and this was
associated with availability of endonuclease activity. Genetic modulation of apoptosis in human neoplasms is
likely to influence net growth rate, retention of cells acquiring new mutations and response to certain
chemotherapeutic agents.
Recently it has become clear that oncogene and oncosuppres-
sor gene activity can influence the probability of cell death as
well as that of cell replication. Expression of c-myc appears
to be associated with a cellular state in which DNA replica-
tion occurs provided suitable growth factors are present, but
from which cells die by the process of apoptosis should these
growth factors be withdrawn (Evan et al., 1992). Hence,
somewhat paradoxically, induction of c-myc expression in
factor starved cells leads to death. The oncogene bcl-2 has a
major effect in protecting cells from apoptosis, including the
apoptosis induced by c-myc and a variety of other stimuli,
physiological and otherwise (Fanidi et al., 1992; Bissonnette
et al., 1992). Activated v-abl oncogene has also been shown
to rescue cells from apoptosis (Evans et al., 1993). In con-
trast, expression of the p53 oncosuppressor gene has been
reported to initiate apoptosis in epithelial, lymphoid and
myeloid cells (Yonish-Rouach et al., 1991; Shaw et al., 1992;
Clarke et al., 1993). Furthermore, mice that are homozygous
for a targeted deletion of the retinoblastoma oncosuppressor
gene (Rb-i) die in utero, showing a striking increase in
apoptosis in particular locations within the developing ner-
vous system (Clarke et al., 1992; Lee et al., 1992; Jacks et al.,
1992). No mechanism has been proposed whereby these
important genes exert their control over programmed cell
death.
In this paper we provide evidence for the regulation of
susceptibility to apoptosis by ras as well as myc oncogenes,
and indicate a possible mechanism for its control. We have
constructed a family of cell lines by independent transfections
of the human c-myc and mutated (T24) Ha-ras oncogenes
into a common parental rat fibroblast. We show that, under
conditions in vitro in which the members of the family are
closely similar in terms of proliferation, apoptotic rates differ
over a fifteen-fold range. In confirmation of previous
independent reports by ourselves and others, we show that
high apoptotic rates are associated with c-myc expression and
we present new data that expression of the Ha-ras oncogene
has the opposite effect. These differences in apoptotic rates
are associated with differences in the cellular content of an
endogenous endonuclease, considered to be one of the
effector elements of apoptosis (Wyllie, 1980; Arends et al.,
1990; Wyllie et al., 1992). The results suggest that one action
of these oncogenes is to influence the availability of apoptosis
effector proteins, in a manner analogous to their action on
proteins critical for cell replication.
Materials and methods
Cell lines
The parent cell line, the Fischer rat lung fibroblast 208F
(Quade, 1979), was transfected with human c-myc linked to
the Moloney virus LTR and a Hygromycin resistance marker
(pHRMCGMI) using electroporation. Selection with Hygro-
mycin B (HmB) was followed by picking single colonies as
monoclonal cell lines (M7 and M8). The presence of exo-
genous DNA was confirmed by Southern analysis and PCR
using c-myc specific primers. Human myc RNA expression
was confirmed by reverse transcription-PCR using exon con-
nection primers and RNA dot blot analysis (data not
shown). A third c-myc transfectant was constructed
independently by calcium phosphate transfection of
pMCGM 1 and neomycin selection (Spandidos & Wilkie,
1984). These were compared with transfectants of 208F cells
containing the mutated T24-ras oncogene with a codon 12
valine substitution (Santos et al., 1982). TI was generated by
calcium phosphate transfection of the high expression plas-
mid pHO5TI, in which the T24-ras is linked to the SV40
enhancer and a neomycin resistance gene (Spandidos & Wil-
kie, 1984). T2 and T3 contain pHO5TI modified to include a
Hygromycin B resistance gene. Clones of these two transfec-
tants were selected with HmB following electroporation. The
parental line, 208F, was also transfected with non-oncogene-
containing vector alone (pHomer5) and similarly selected by
drug resistance, the resulting transfectants were non-
transformed and appeared morphologically identical to the
parental 208F cells. The presence of exogenous DNA was
confirmed by Southern hybridisation analysis and PCR using
Ha-ras specific primers (data not shown) (Bos et al., 1987),
and enhanced expression of p21ras confirmed by
immunocytochemistry as described below.
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Cells were seeded into flasks in quadruplicate. 20 ml of
Glasgow's Modification of Eagles Medium (GMEM) and
10% Heat Inactivated Newborn Calf Serum (HINCS) was
added and the flasks maintained at 37°C in a 5% CO2
atmosphere for 48 h prior to analysis. The number of cells
added was sufficiently low to avoid the establishment of a
confluent monolayer by 48 h, as confluent monolayers tend
to demonstrate increased apoptosis (Perotti et al., 1990).
Cells were initially grown in the presence of GMEM/10%
HINCs. At approximately 50% cell confluence the media was
replaced by 20ml of (i) fresh GMEM supplemented with
10% HINCS, (ii) fresh GMEM with 0.01% HINCS, (iii)
GMEM without serum, or (iv) serum-free GMEM with
added 25 p.M mevinolin, and thereafter the cultures were
maintained at 37'C for 48 h. Mevinolin (lovastatin) (kindly
donated by Dr Alberts) was converted to its sodium salt
prior to use as described by Kita et al. (1980).
Detection of ras product
Cell monolayers were harvested and resuspended in 2 ml of
GMEM with 10% HINCS. 0.25 ml of cell suspension was
added to sterilised slides, placed in sterile multiplate dishes
(Lux Scientific Corporation). The cells were allowed to
adhere (6-10 h) before being flooded in GMEM with 10%
HINCS. After 48 h of growth in a humidified 5% CO2
atmosphere at 37°C the slides were washed in PBS and fixed
for 4 min at room temperature using PLPD, a fixative known
to be optimal for subsequent detection of p2lras with
antibody Y13-259 (Going et al., 1988). Slides were washed in
PBS and allowed to dry before storage at - 20°C.
Relative levels of p21 ras protein expressed by each cell line
were measured in immunocytochemical preparations (Wil-
liams et al., 1985; Going et al., 1988) using the monoclonal
antibody Y13-259 that specifically recognises p21ras proteins
(Furth et al., 1982). The antibody was serially diluted in 20%
newborn goat serum (NGS) to concentrations ranging from
1:500 to 1:20,000, and each dilution was pipetted on to a
separate cell preparation for incubation for 30 min at room
temperature, washed and detected by biotinylated goat anti-
rat antibody diluted 1:50 in 20% NGS incubated for 30 min
at room temperature. This was followed by three drops of
avidin-biotin complex containing biotinylated peroxidase
(ABComplex; Dako) for 30 min, two washes, and the reac-
tion was visualised with excess 3,3-diaminobenzidine tetra-
hydrochloride (DAB) solution for exactly 4 min. Samples
with brown reaction product deposited on the membrane or
in the cytoplasm of greater than 5% of cells were scored
positive.
Cell turnover parameters
A proportion of fibroblasts growing in culture die by releas-
ing contacts with their neighbours and the substratum, con-
tracting in size, rounding up and floating as cellular bodies in
the culture medium. This process was confirmed as apoptosis
by fluorescence and electron microscopy of the cell bodies
harvested from the media, which showed the characteristic
morphology of apoptosis. (Wyllie et al., 1980; Wyllie, 1987;
Arends & Wyllie, 1991) and gel electrophoretic analysis of
extracted DNA, which demonstrated the typical 'chromatin
ladder' representing oligonucleosomal fragments due to DNA
cleavage by endogenous endonuclease (data not shown).
Apoptosis was measured as the number of apoptotic
bodies accumulated over 2 days by a subconfluent mono-
layer. 75 cm2 flasks were seeded with 1-8 x I05 cells to
generate, after 48 h, monolayers of 50% - 80% confluence.
The overlying medium was collected, including a further PBS
rinse that was swirled over the monolayer cells, and together
these were centrifuged at 3000 rpm for 10 min. Cell bodies
released from the monolayer into the media - Released Cell
Bodies (RCB) - were resuspended in a known volume of PBS
and the total numbers of RCB were counted by haemocyto-
meter. Twenty pl of this sample was mixed with an equal
volume of 10 fig ml acridine orange on a glass slide and
viewed under UV light. One to two hundred cellular bodies
were counted and identified as viable, apoptotic or necrotic -
on the basis of their characteristic morphological appear-
ances (Kerr et al., 1972; Wyllie et al., 1980; Arends & Wyllie,
1991). This was used to calculate the proportion of apoptotic
bodies (%A) and viable (%V) cells comprising the RCB. The
monolayer was carefully harvested, ensuring complete re-
moval of residual cells from the substratum by phase con-
trast microscopy, and counted by Coulter Counter (Model
ZM; Coulter Electronics) and haemocytometer, to enumerate
the total number of monolayer cells (MC). The apoptotic
index (Al) was calculated as a measure of the production of
apoptotic bodies per 100 attached cells over 48 h, using the
following equation:
Apoptotic Index = [%A x RCB x 100]4(%V x RCB) + MC]
The rate of population expansion (PE) was assessed as the
ratio of the mean monolayer- cell number at 48 h to that at
24 h, in triplicate subconfluent experiments, whilst the cells
were in maximal growth phase. This was calculated as a
single measure of the proportional increase in cell number
over one day, in order to compare different cell lines.
Cell proliferation was analysed for each cell line, using
nuclei prepared for flow cytometric measurement of DNA
content (Vindelov et al., 1983), harvested from monolayers
growing in log phase. The computer software program,
PARA 1 (Coulter Electronics), was used to determine the
proportion of cells in each phase of the cell cycle. The
alternative program SFITS (Coulter Electronics) was also
used and gave very similar data. The growth fraction (GF)
was calculated as the proportion of cells in S plus G2/M
phases of the cell cycle.
Endogenous endonuclease activity
To obtain a semi-quantitative assessment of the nuclear
endonuclease activity associated with viable cells in each cell
line, subconfluent monolayers were prepared and fed with
either GMEM/10% HINCS or GMEM/0.5% HINCS, for
24 h and again for 4 h prior to harvest. At harvest,
monolayers were rinsed twice with PBS to remove any apop-
totic cells in the supernatant, and the monolayers were strip-
ped with trypsin and EDTA as before. Nuclei were prepared
by isotonic lysis and centrifugation through a glycerol
gradient (Arends et al., 1990). Approximately 107 nuclei were
resuspended in 200,u1 incubation buffer containing 100 mM
Tris-HCl, 2 mM CaCl2, with or without MgCl2 at 2 mM, and
incubated at 37°C for 18 h. Previous studies in this
laboratory (data not shown) have suggested that these condi-
tions are likely to produce maximal demonstration of endo-
nuclease activity with preference for internucleosomal
cleavage. 2 mM zinc ions were also added to the incubation
buffer in some experiments to inhibit nuclease activity
(Cohen & Duke, 1984). DNA from these incubations was
phenol/chloroform extracted, ethanol precipitated and
analysed by 2% agarose gel electrophoresis, to reveal
chromatin cleavage by the endogenous endonuclease activity.
Prior to incubation, more than 99% of the nuclei were found
to be non-apoptotic as judged by acridine orange staining
and UV fluorescence microscopy.
Chromatin cleavage into the characteristic oligonucleo-
somal 'ladder' pattern of apoptosis was observed. To obtain
a quantitative measure of the extent of digestion to lower
order nucleosomal fragments, photographs of the ethidium
bromide stained gels were scanned by laser densitometer
(Ultrascan XL, enhanced laser densitometer, LKB). For each
cell line a 'Digestion Ratio' (DR) was calculated. The DR
numerator was the amount of DNA fluorescence in the lower
order oligonucleosomes that comprised the mono-and di-
nucleosomes together with the lower half of the tri-
nucleosomal DNA band (an arbitrary cut off chosen for its
accurate reproducibility on the densitometry graph), whereas
the DR denominator was the total DNA fluorescence in the
electrophoretic track, including the high molecular weight
DNA smear.
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Results
Myc and ras transfectants show similar measures of
proliferation but divergent apoptotic rates
The six cell lines resulting from transfection of 208F with
c-myc and T24-ras DNA all showed closely similar prolifera-
tion rates, analysed as Growth Factions (S + G2/M phases of
the cell cycle) during growth in log phase in 10% serum, and
there were no statistically significant differences by ANOVA
or Kruskal-Wallis tests (Table I). In contrast, the apoptotic
indices differed from each other by more than fifteen-fold
under these conditions (Figures 1 and 2a). The three c-myc
transfectants showed significantly higher levels than the con-
trol 208F (P<0.004 in call cases), and apoptosis was further
increased by serum deprivation (0.01% serum) (P<0.004 in
all cases) (Figure 1). Two of the three T24-ras transfectants,
TI and T2, showed significantly reduced apoptosis compared
to the control 208F (P= 0.004 and P= 0.005 respectively)
(Figure 2a). T3, the third of the T24-ras transfectants,
showed an apoptotic index not significantly different from
the parental line. As expected, these large differences in apop-
tosis had great effects on the overall population expansion
rates of the monolayers as a whole, and these two parameters
showed a strong inverse correlation (r =-0.77) for the six
oncogene transfectants (Table I).
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High expression of mutated ras is associated with reduced
apoptosis
We sought to establish the role of ras in modifying apoptosis
by two classes of experiments. In the first, the three ras
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Table I Cell turnover parameters
Population Apoptotic
Cell line Growth fraction expansion index
208F 41.7 (± 2.98) 1.53 6.98 (± 1.75)
Ml 44.3 (±2.17) 2.89 26.5 (±7.97)
M7 41.8 (±3.37) 1.54 30.2 (±11.1)
M8 45.5 (±2.96) 1.20 15.4 (±4.44)
TI 46.2 (± 1.17) 3.56 1.7 (±0.14)
T2 45.9 (±1.62) 3.67 2.2 (±0.12)
T3 41.0 (± 1.32) 1.77 8.4 (± 3.07)
Growth Fraction data (S + G2/M phases of the cell cycle analysed
flow cytometrically using the PARA 1 program) are means (± s.e.m.)
of 9 -10 experiments and show no statistically significant differences
by ANOVA or Kruskal-Wallis tests. Population Expansion (PE)
data are means of triplicate experiments. Apoptotic Index (Al) data
(at 10% serum) are means (± s.e.m.) of 6-21 experiments and were
log transformed to normalise the distributions for statistical analysis.
The means of the log AI values for the six oncogene transfectants
correlate inversely (r = - 0.77) with their PE values.
e.m. High serum
-L
x 2-
a)T
1.5-
C.2
40
0
0.
(a 0.5
CD
0
-0.5
Ml M7 M8
Low serum
1T_
I~
208F
Cell line
Figure 1 The 3 c-myc transfectants Ml, M7 and M8 show more
apoptosis than the control 208F, when grown at high (10%)
serum (P<0.004 for all comparisons, Student's t-test on log AI
data, based on eight experiments). There is a further increase in
apoptosis during growth in low (0.01%) serum, compared with
the high serum values and that of the control 208F at low serum
(P<0.004 in all comparisons, Student's t-test on log Al data,
based on 20 experiments).
Figure 2 a, The 2 T24-ras-transfectants, T 1 and T2 show less
apoptosis than the control 208F cells, when grown at 10% serum
(P = 0.004 and P = 0.005 respectively). Under conditions of
serum deprivation, Ti shows a lower apoptotic index than 208F
(P = 0.006), whereas T2 and T3 demonstrate higher rates
(P = 0.004 and P<0.0000I respectively). The addition of 25 jM
mevinolin to serum-deprived cultures resulted in a considerable
increase in the apoptotic index for all 3 T24-ras transfectants
compared to 208F (P<0.00001 in all cases) (all comparisons by
Student's t-test, based on eight experiments). No significant
change in the apoptotic index of 208F was observed. b, Apoptotic
indices for ras transfectants and 208F cells grown at 10% serum
are compared with relative levels of p21ras expression (arbitrary
units). High and intermediate levels of p2Iras expression (Ti and
T2) are associated with significantly lower rates of apoptosis than
that of the control, whereas a low level of p21 ras expression (T3)
is associated with an apoptotic index similar to 208F. Apoptotic
indices correlated inversely (r = - 0.72) with p2lS expression.
transfected lines were compared in terms of apoptotic rate
and relative levels of expression of p21ras, measured semi-
quantitatively as the dilution of antibody Y13-259 at which
membrane staining of monolayer-cultured cells was no longer
evident. Whereas expression of p2lras in T3 was approxi-
mately two-fold greater than in the parental line, T2
exhibited four-fold greater expression, and TI ten-fold
greater expression by this method (Figure 2b). These semi-
quantitative assessments of p21ras protein expression cor-
related well with estimates of the relative copy number of the
transfected genes obtained from Southern hybridisation and
densitometric analysis of the three cell lines (data not shown).
The levels of p21ras detected showed an inverse correlation
with apoptotic indices (r = - 0.72). Growing in log phase in
10% serum, apoptosis was lowest in the cell line with the
highest copy number and p2lras expression (TI) and highest
in T3 in which expression and copy number were lowest. T2
showed an intermediate pattern both in p21l expression and
apoptosis. Even in serum-deprived conditions, TI showed
low levels of apoptosis and retained high expression of p2lras.
In contrast, both T2 and T3 showed elevated apoptotic rates
under these conditions with reduction in p2Iras expression to
undetectable levels (data not shown).
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In a second series of experiments the isoprenylation inhibitor
mevinolin was used in an attempt to inhibit the biological
activity of the p2Iras protein by blocking its membrane
attachment. Mevinolin, applied to serum-deprived cultures at
a concentration known to inhibit p2Iras function (Hancock et
al., 1989; Schafer et al., 1989; De Clue et al., 1991), had little
effect on the apoptotic rate of the parental 208F cell line. In
contrast, there was a profound increase in apoptotic rates in
all three T24-ras transfected lines, compared with apoptosis
in its absence (P<0.001 in all cases) (Figure 2a). The paren-
tal line 208F showed no significant increase in apoptosis
following treatment with mevinolin indicating that low level
endogenous ras within this line is presumably not the prime
regulator of apoptosis.
Cellular content of endogenous endonuclease varies in
proportion to susceptibility to apoptosis
Previous experiments have shown that lymphoma cells about
to enter apoptosis accumulate an endogenous endonuclease
which can be activated by calcium and magnesium ions
(Wyllie et al., 1986b and 1992). Elsewhere we have described
such cells as 'primed' for apoptosis, to distinguish them from
cells lacking this component of the effector pathway of apop-
tosis (Arends & Wyllie, 1991). It was therefore of interest to
compare the nuclear content of this calcium/magnesium sen-
sitive endonuclease (or endonuleases) in log phase cultures of
the transfected cell lines. Parallel incubations of nuclear
preparations from the parental and transfected cell lines
revealed several consistent differences. First, incubation of
the nuclei from many of the cell lines for several hours
frequently produced internucleosomal cleavage of chromatin
which was optimum in the presence of calcium plus mag-
nesium ions, but could be inhibited by zinc ions (Figure 3).
In every case, more than 99% of the nuclei showed a normal
morphology (i.e. without the stigmata of apoptosis) prior to
incubation. The three myc transfectant lines (Ml, M7 and
M8) consistently showed the highest nuclear content of the
enzyme, as evident by the intensity of ethidium bromide
staining of the chromatin ladder from equivalent cell
numbers. The high p21raS expressing cell line Tl consistently
showed only minimal evidence of internucleosomal cleavage,
even after overnight incubation with calcium and magnesium
ions. The two T24-ras transfectants with lower levels of p2lras
expression (T2 and T3) generated fragmented chromatin to a
varying degree, which was most conspicuous in cells
harvested after several hours incubation in low serum (Figure
4). At high serum concentration there was some cleavage of
chromatin, mostly to large oligonucleosomal fragments, but
at low serum a greater proportion of digested chromatin
appeared as small oligonucleosomes. This was confirmed by
densitometric measurement of DNA bands and calculation of
'Digestion Ratios' (DR). Compared with serum supple-
mented cells, the DR increased in assays of serum-deprived
T2 (from 27% to 45%) and T3 (from 53% to 61%), indicat-
ing more complete digestion to smaller oligonucleosomal
chains by the endonuclease activity present in populations of
serum deprived cells. The calcium and magnesium ionic sen-
sitivity of the endonuclease activity was confirmed in T2 and
T3 nuclei prepared from cells grown at both serum concen-
trations. In contrast, TI showed no significant endonuclease
activity at low serum, whereas M8 demonstrated marked
nuclease activity at high serum that was further increased by
serum deprivation (Figure 4).
Discussion
C-myc is associated with a high turnover state
The data show that cell lines of common rat fibroblast
parentage can vary fifteen-fold in rates of apoptosis, whilst
retaining similar cell proliferation kinetics. The high apop-
totic indices in the c-myc transfectants confirm the observa-
tion made by ourselves and others that constitutive c-myc
208F Ml M8
a b a b a b
M7
a b
M8
c M
A
Tl
a b M
B
Figure 3 A, Ionic sensitivity of endogenous endonuclease activity
within nuclei prepared from viable cells. This shows DNA ext-
racted from nuclei following autodigestion in the presence or
absence of magnesium and calcium ions (tracks marked a for
both ions, tracks marked b for calcium ions only). Although the
parent 208F shows little chromatin digestion, the c-myc transfec-
tants, Ml and M8, show chromatin cleavage at internucleosomal
sites which is more marked when both cations are present. Sam-
ples from the T24-ras transfectant T1 show only high molecular
weight DNA with no detectable endonuclease activity. B, In a
separate experiment M7 shows a similar pattern of chromatin
cleavage to Ml and M8. Furthermore, M8 chromatin autodiges-
tion in the presence of magnesium and calcium ions is completely
inhibited by zinc ions (track marked c). One kb ladder marker
tracks (M) are included and these indicate that chromatin is
cleaved into fragments that are multiples of the length of DNA
wrapped around a single nucleosome (180-200 bp).
activation is associated with initiation of apoptosis, parti-
cularly in cells in which cell-cycle progression is inhibited by
a variety of circumstances including reduced serum growth
factor support (Wyllie et al., 1987 and 1992; Askew et al.,
1991; Bertrand et al., 1991; Evan et al., 1992). However,
there is incomplete data regarding the regulation of apoptosis
by endogenous myc in normal fibroblasts. These conclusions
may not apply to all cell types as some appear to die by
apoptosis following the disappearance of myc (Yuh &
Thompson, 1989). The c-myc transfectants reported here
appear to be in a 'high turnover' state whilst growing in log
phase, in which cell proliferation and death by apoptosis
co-exist, so that the overall population expansion is substan-
tially slower than expected from consideration of the cell
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Figure 4 Serum sensitivity of endogenous endonuclease activity
in viable nuclei. Cells were grown for 24 h and a further 4 h in
either low serum (0.05% HINCS - tracks marked Lo) or high
serum (10% HINCS - tracks marked Hi) prior to analysis. M8
shows autodigestion of chromatin into oligonucleosomal
fragments at both serum concentrations, with an increase in
digestion to lower order oligonucleosomes at low serum levels. Ti
shows no significant chromatin digestion at either high or low
serum. T2 and T3, show pattems of chromatin digestion which
differ according to the serum concentration prior to cell harvest
and the ionic content of the assay solution. Chromatin digestion
in the presence of both calcium and magnesium ions (tracks
marked CM) is consistently greater than with calcium ions alone
(tracks marked C). Both T2 and T3, cultured in high serum,
show low or intermediate levels of chromatin digestion, the resul-
tant fragments being relatively depleted in low order
oligonucleosomes. In contrast, after culture in low serum,
chromatin digestion into lower order oligonucleosomes is greater.
The overall pattern is one of serum sensitive expression of
endonuclease activity in T2 and T3. One kb ladder marker track
(M) is included.
proliferation rate alone. There was no other obvious means
of exit from the proliferating pool in these cultures (such as
necrosis or differentiation). Thus, the rate of apoptosis
appears to be the major regulator of the rate of population
expansion for these cell lines growing in culture. Further-
more, high turnover states of this sort are almost universal in
tumours growing in vivo in which deregulation of c-myc is
also a common event (Field & Spandidos, 1990), supporting
an important role for apoptosis in determining net tumour
growth in vivo, although c-myc may not be the only cellular
protein of significance in this regard.
Mutated Ha-ras is associated with suppression of apoptosis
Of the mutated Ha-ras transfectants, two lines showed sup-
pressed apoptosis relative to the control. In experiments of
this design, in which ras expression is not selectively reversi-
ble, it is not possible to be completely certain that the
differences in apoptotic rate are due exclusively to expression
of the transfected oncogene rather than incidental cellular
changes arising during transfection and selection. We show
here, however, that inhibition of apoptosis is proportional to
expression of functional p21ras protein in the three indepen-
dent transfectants, following serum withdrawal and immedi-
ately after blockade of p2lras processing by mevinolin in
dosages previously shown to be effective in inhibition of
isoprenylation (Hancock et al., 1989; Schafer et al., 1989;
DeClue et al., 1991). Strikingly, this pharmacological
blockade induced similarly high apoptotic rates in all the
three T24-ras transfectants although there was no immediate
toxic effect in the parental 208F fibroblast. Inhibition of ras
expression has been reported to precede, and perhaps be a
prerequisite for apoptosis of cultured chloroleukemic cells
(Servomaa & Rytomaa, 1988). In a mouse mast cell line
transfected with human activated Ha-ras oncogene in a
regulable construct, ras activation was also associated with
rapid growth, whilst reduced ras expression was accompanied
by cell death (Andrejauskas & Moroni, 1989).
Susceptibility to apoptosis reflects availability of endonuclease
in viable cells
We have argued elsewhere that entry to apoptosis requires
two cellular events: 'priming', in which the effector proteins
for apoptosis accumulate within the cell, and 'triggering', in
which these proteins are activated (Arends & Wyllie, 1991;
Dive & Wyllie, 1993). By implication, cells might exist in an
unprimed state in which apoptosis would be impossible, at
least temporarily, until the effector proteins accumulated.
Certain cell types such as cortical thymocytes appear sen-
sitive to apoptosis induced by a wide variety of disparate
agents: ligands for the T cell receptor, ionising radiation,
etoposide, toxic agents such as TCD-Dioxin, or steroid hor-
mones (Van Haelst, 1967; Umansky et al., 1981; Wyllie &
Morris, 1982; Wyllie et al., 1984; McConkey et al., 1988;
Yamada & Ohyama, 1988; Smith et al., 1989; Walker et al.,
1991). These stimuli have clearly different initial effects upon
the thymocyte, as shown by the fact that calcium signalling
(McConkey et al., 1989a and 1989b) and p53 dependence
(Clarke et al., 1993) are features of some but not all of them.
Nonetheless, apoptosis is the final common event, complete
with chromatin condensation and activation of an endo-
genous endonuclease which appears to be present consti-
tutively in these cells (Wyllie, 1980; Arends et al., 1990).
Similarly, divergent stumuli such as c-myc expression
together with growth arrest or exposure to etoposide can
induce apoptosis in cultured fibroblasts (Evan et al., 1992;
Fanidi et al., 1992). However, fibroblasts and lymphocytes
can be rendered insensitive to apoptosis in response to a
similar variety of stimuli by suitable gene expression, such as
ras as shown here and bcl-2 (Vaux et al., 1988; Nunez et al.,
1990; Hockenbery et al., 1990; Evan et al., 1992; Fanidi et
al., 1992; Bissonnette et al., 1992; Wyllie et al., 1992). The
mechanism whereby these changes in susceptibility to apop-
tosis are engendered is not known, but one of the possibilities
is that elements within the apoptosis effector pathway may
themselves be regulable.
This proposition is difficult to test as no element of the
effector pathway has been definitively identified and purified.
In this paper, we have examined the availability of a nuclear
calcium/magnesium sensitive endonuclease (or endo-
nucleases), whose activity is apparently responsible for the
chromatin cleavage of apoptosis and is induced prior to the
onset of chromatin condensation (Wyllie et al., 1986a, 1986b,
1992 and 1993; Arends et al., 1990; Walker et al., 1991).
Endonuclease activation appears to be a mid to late event in
apoptosis, as in programmed cell death in other circum-
stances (Hengartner et al., 1992) and may provide a useful
indication of the cells' ability to undergo the process as a
whole. Here we demonstrate that abundance of readily acti-
vated endonuclease in viable fibroblast nuclei is associated
with susceptibility of these cells to undergo apoptosis, being
high in c-myc transfectants, apparently absent in the T24-ras
transfectant, TI, with the lowest apoptotic rate and the
highest expression of p2lras oncoprotein, and substantially
increased in serum-deprived cultures of the intermediate and
low p2lras expressing lines, T2 and T3, in which apoptosis is
also increased. Therefore, these experiments provide evidence
for a mechanism whereby oncogenes may regulate apoptosis,
even in the absence of definitive information concerning any
of the effector molecules. Hopefully, when these effectors are
isolated, it will be possible to test more precisely the
hypothesis advanced here.
The role of oncogene modulation of apoptosis in tumour growth
Finally, the question arises as to the role of ras and myc
oncogenes in the growth of authentic human tumours. The
data reported here show that differences in myc and ras
oncogene expression, are not limited to effects upon cell
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proliferation, but can profoundly influence overall population
expansion through modifying apoptosis. Elsewhere we show
(Arends et al. unpublished data) that these transfected cell
lines have differences in their rates and aggressiveness of
tumour growth in vivo that correspond to the phenomena
described here in vitro, extending the previously published
data (Wyllie et al., 1987) that showed that a T24-ras express-
ing cell line (TI) produced a higher primary tumour take-rate
and a significantly higher proportion of test mice with metas-
tasis at 14 days, compared with a c-myc expressing line (MI).
There is also evidence from human pathology that expression
of myc is associated with tumours with high cell turnover
(Field & Spandidos, 1990), whereas ras expression or
oncogenic activation is associated with cell population expan-
sion in potentially premalignant tumours of the colon and
breast, rather than acquisition of specific features of the
malignant phenotype (Williams et al., 1985; Going et al.,
1992). Thus, the data support the hypothesis that oncogenes
such as ras and bcl-2 can suppress apoptosis (Vaux et al.,
1988; Hockenbery et al., 1990; Nunez et al., 1990). Reduction
of apoptosis directly causes an increase in population expan-
sion likely to produce greater retention of cells acquiring new
mutations (Wyllie, 1985), increasing the risk of malignant
transformation in a population of cells in a premalignant
lesion, or increasing tumour progression in an already malig-
nant population of cells, and both of these have been
associated with ras activation (Brown et al., 1986; Buchmann
et al., 1991). Furthermore, genetic modulation of apoptosis,
by myc, bcl-2 and p53, determine to a large extent the
cellular response to certain anticancer chemotherapeutic
agents such as etoposide (Walker et al., 1991; Fanidi et al.,
1992; Clarke et al., 1993; Evans & Dive, 1993). Thus, the
levels of apoptosis in tumours appear to influence net
growth, acquisition of new properties, and response to cer-
tain cytotoxic agents, and susceptibility to apoptosis is
regulated by many genes including myc and ras.
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authors also thank the Cancer Research Campaign, Scottish Home
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